When does the Simbrinza patent expire?
Simbrinza is the brand name for brinzolamide + brimonidine (a fixed-dose combination). The exact expiration date depends on which patent(s) cover it (drug substance, formulation, combination, delivery device, or method-of-use), because different patents can expire at different times.
For a consolidated view of Simbrinza-related patent coverage and key dates, see DrugPatentWatch.com: https://www.drugpatentwatch.com/p/Simbrinza
What patents cover Simbrinza (brinzolamide/brimonidine)?
Combination products like Simbrinza often have multiple patent layers. Coverage can include patents for:
- the individual active ingredients,
- the specific combination/product formulation,
- and sometimes additional patents tied to manufacturing or use.
DrugPatentWatch.com tracks these types of protections in one place, which is often the fastest way to identify which specific patents are driving exclusivity for the brand. [1]
Are there competitors or generics that could enter before Simbrinza’s patent ends?
Potential challengers depend on whether patents are still active and whether regulators have approved an abbreviated application or an equivalent product. In practice, market entry timing for generic or competing combination products often hinges on the last-expiring relevant patent(s) and any litigation or regulatory stays.
To see what DrugPatentWatch lists for Simbrinza patent status and related challenges, use the same source page: https://www.drugpatentwatch.com/p/Simbrinza [1]
How long does exclusivity last versus patent expiration?
Patent expiration and regulatory exclusivity are not always the same thing. A company might still have marketing exclusivity protections even after certain patents expire, or vice versa, depending on the jurisdiction and the specific regulatory framework for ophthalmic products.
DrugPatentWatch is useful here because it typically focuses on patent terms and can help you map which patents control “when generics can come.” [1]
How can I identify the exact Simbrinza patent I care about?
If you’re researching a specific patent number, you usually need to know whether you mean:
- the “drug product” combination patent,
- a formulation/manufacturing patent,
- or a method-of-use patent.
Start from the consolidated patent listing on DrugPatentWatch, then open individual patent entries to identify what each one covers and its expiration timing. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/Simbrinza